Profile picture

Doctor Francesco Fusco

Copenhagen (Denmark)
Follow
Logo ESC

Contributor content

Potential real-world benefit of semaglutide 2.4 mg on cardiovascular outcomes in the UK based on the SELECT trial
Presentation
Potential real-world benefit of semaglutide 2.4 mg on cardiovascular outcomes in the UK based on the SELECT trial
Read more

ESC 365 is supported by

novartis Explore sponsored resources